Survival of the myocardical revascularization implanted to the affiliated to the Obligatory Plan of Health (OPH) of Susalud EPS, Colombia, 1999-2004

Authors

  • Diana P. Jaimes
  • Claudia T. Osorio
  • Hugo Grisales

DOI:

https://doi.org/10.17533/udea.rfnsp.199

Keywords:

survival, coronary illness, myocardical revascularization, fault probability

Abstract

Objective: to describe the survival of myocardical revascularization in patients affiliated to the obligatory plan of health (OPH) of Susalud company in five Colombian cities between 1999 and 2004. Materials and methods: 720 myocardical revascularizations were considered from which their characteristics were included in a database of Susalud. A life table and the survival function curve of the myocardical revascularization were built. The association of this information with variables of person by Kaplan Meier’s method and the log rank test was explored. Results and conclusions: from the moment of the surgery until six years later the durability of the myocardical revascularization reached 86.3%: 92,8% for men and 72.9% for women. The probability of fault of the myocardical revascularization presented a remarkable reduction during the first 9 months. Since this time on it had little variability until the sixth period (53.1 months). In the next period it had an important increase (62-70.9 months). A high probability of fault in the early postsurgery period as well as at the end of the study is pointed out. The durability of the myocardical revascularization was also associated with, and it was found that 50% of the implants that fail in women doubled durability of those implanted to men. The present research can be a starting point for future investigations on survival of the myocardical revascularization that include clinical variables that can influence in it.
|Abstract
= 269 veces | PDF (ESPAÑOL (ESPAÑA))
= 49 veces|

Downloads

Download data is not yet available.

References

(1). Hunt D, Young P, Simes J, Hague W, Mann S, Ow-ensby D, et al. Benefits of pravastatin on cardio-vascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID Trial Ann Intern Med 2001; 134:931-40. DOI: https://doi.org/10.7326/0003-4819-134-10-200105150-00007

(2). Grupo Científico de la Organización Mundial de la Salud. Factores de riesgo de enfermedades cardio-vasculares: Nuevas esferas de investigación. Ginebra. Organización Mundial de la Salud 1994 (Serie Informes Técnicos; 841).

(3). Jacquet L, Noirhomme P, El Khoury G, Goenen M, Philippe M, Col J et al. Coronary bypass surgery. Eur J Cardiothorac Surg 1998,13(4):378-84. DOI: https://doi.org/10.1016/S1010-7940(98)00032-3

(4). Caballero Valdés. Factores de riesgo cardiovascular. Rendimiento a largo plazo de las recomendaciones en los reconocimientos laborales. MAPFRE medici-na 1992; 3(Sup. 5):34.

(5). Montoya Restrepo NE. Situación de salud y carac-terísticas de los afiliados al POS,Susalud,EPS, 2004. Medellín: Susalud; 2005.

(6). Grisales H. Estadística aplicada en salud pública: estadística descriptiva y probabilidad. Medellín: L. Vieco e Hijas; 2002. p. 82

(7). Sahai H. Análisis multivariado de datos epidemioló-gicos. Universidad de Puerto Rico, Puerto Rico, En: Simposio de Estadística. Puerto Rico; Universidad Nacional de Colombia, Facultad de Ciencias. Depar-tamento de matemáticas y estadística; 1994. p. 162.

(8). Sociedad Peruana de Cardiología. Factores de ries-go de morbilidad y mortalidad en revascularización miocárdica. Hospital Nacional Edgardo Rebagliati Martins Estudio de 168 casos.Rev peru cardiol 2004; 30 (1): 29-38.

(9). Pineda Correa M, Matiz Camacho H, Rozo Uribe R. Enfermedad coronaria, Tratamiento quirúrgico de la enfermedad coronaria. Bogota: Kimpres; 2002. p 168-74.

(10). Bahamondes J, Merino G, Silva von E A, Salaman J. Revascularización miocárdica de la arteria des-cendente anterior con arteria mamaria interna izquierda con circulación extracorpórea: seguimiento a 10 años. Rev méd Chile 2005; 133 (8):881-6. DOI: https://doi.org/10.4067/S0034-98872005000800003

(11). Hospital de la Santa Creu i Sant Pau. Hemodiná-mica y cardiología intervensionista. Barcelona: El Hospital; 1998.

(12). Health Day, American Heart Association, Hispani Care, traductor. El tamaño del cuerpo importa tras un bypass. Medline Plus. 29 de agosto de 2005; News release.

(13). Grondin CM. Reoperation in patients with coronary graft disease. Cardiovasc Clin Vol. 1987; 17 (3): 31-9

Published

2008-10-23

How to Cite

1.
Jaimes DP, Osorio CT, Grisales H. Survival of the myocardical revascularization implanted to the affiliated to the Obligatory Plan of Health (OPH) of Susalud EPS, Colombia, 1999-2004. Rev. Fac. Nac. Salud Pública [Internet]. 2008 Oct. 23 [cited 2025 Apr. 1];25(1):1-13. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/199

Issue

Section

Research